How does the use of checkpoint inhibitors for treatment of HCC impact timing of liver transplant and subsequent immunosuppression?  

This is a challenging issue with concerns for checkpoint inhibitor/immunotherapy (IO) resulting in rejection of a transplanted organ. In our practice, we have a local protocol based on our consensus that at least 6 weeks of washout for IO prior to transplantation. Post-transplantation, IO is not use...